Medicines gonna med, surgeons gonna surge. What do we change and do in the perioperative period? Join us for some bites from the MHP 2023 talk on Perioperative management updates, a few JHM articles around NPO status and buprenorphine continuation, and the start of a summary series on SPAQI position papers on what to do with various medications in the perioperative period.

| 00.22 - TOC |

| 01.17 - MHP-1 Post-operative AFib and Anticoagulation [Siontis 2022 - Associations of POAF w/ subsequent outcomes] [AHA 2023 guidelines] |

| 02.50 - MHP-2 ASA for DVT ppx in Ortho trauma cases [METRC study - large multi-center trial of ASA vs LMWH] [ICS-VTE position papers by location of surgery] |

| 04.20 - MHP-3 Post-op delirium [AGS Guidlines] [Kim 2022- Haldol vs atypicals] |

| 05.11 - Perioperative NPO status: When should we start? [JHM 2021] |

| 06.37 - Buprenorphine in the acute pain and perioperative settings [JHM 2019] |

| 07.18 - SPAQI position paper on Endocrine, Hormonal, and Urological meds |

| 09.56 - Summary |

[The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the information, products, or services contained therein. UCSF does not exercise any editorial control over the information found therein, nor does UCSF make any representation of their accuracy or completeness. All information contained in this episode are the opinions of the respective speakers and not necessarily the views their respective institutions or UCSF, and is only provided for information purposes, not to diagnose or treat.]

Music by Amit Apte. Surgery Vectors by Vecteezy

018 - Perioperative Pearls I: MHP 2023, SPAQI medrec on endocrine/hormonal meds